Novo Nordisk A/S (NVO) News Today $55.78 +1.41 (+2.59%) Closing price 03:59 PM EasternExtended Trading$55.82 +0.04 (+0.07%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Novo Nordisk A/S (NYSE:NVO) Trading 2.6% Higher - What's Next?1 hour ago | marketbeat.comBehind the Scenes of Novo Nordisk's Latest Options TrendsOctober 20 at 12:48 PM | benzinga.comWhy HIMS, Novo, and Eli Lilly DroppedOctober 20 at 7:47 AM | baystreet.caNovo Nordisk A/S $NVO Shares Sold by Calamos Wealth Management LLCOctober 20 at 5:16 AM | marketbeat.comTrueMark Investments LLC Acquires 24,839 Shares of Novo Nordisk A/S $NVOOctober 19 at 5:38 AM | marketbeat.comSwmg LLC Takes $1.53 Million Position in Novo Nordisk A/S $NVOOctober 19 at 5:37 AM | marketbeat.comNovo Nordisk GLP-1 pill now U.S. approved for heart disease riskOctober 18 at 7:33 PM | msn.comStocks to Watch Recap: American Express, Zions, Novo NordiskOctober 18 at 11:47 AM | wsj.comPrivate Trust Co. NA Trims Stock Holdings in Novo Nordisk A/S $NVOOctober 18 at 5:16 AM | marketbeat.comAtria Wealth Solutions Inc. Sells 24,067 Shares of Novo Nordisk A/S $NVOOctober 18 at 4:07 AM | marketbeat.comNovo Nordisk, Eli Lilly slide after Trump comments on weight loss drug pricingOctober 17 at 8:14 PM | investing.comFDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart RiskOctober 17 at 8:14 PM | msn.comFDA Approves Novo Nordisk's Rybelsus Diabetes Pill to Reduce Heart RiskOctober 17 at 6:01 PM | wsj.comNovo Nordisk A/S (NYSE:NVO) Stock Price Down 3% - What's Next?October 17 at 5:40 PM | marketbeat.comEli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1sOctober 17 at 5:25 PM | cnbc.comHere's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly StocksOctober 17 at 12:15 PM | investopedia.comIs Trump Going to Kill the GLP-1 Cash Cow?October 17 at 11:05 AM | 247wallst.comNovo Nordisk hires US pharma veteran as Trump pricing pressure mountsOctober 17 at 10:51 AM | reuters.comNovo Nordisk, Eli Lilly shares drop as Trump promises lower weight loss drug pricesOctober 17 at 9:23 AM | proactiveinvestors.comEli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to Know.October 17 at 7:18 AM | barrons.comStratos Investment Management LLC Has $6.17 Million Stake in Novo Nordisk A/S $NVOOctober 17 at 6:24 AM | marketbeat.comNovo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss DrugsOctober 17 at 6:23 AM | wsj.comNorthRock Partners LLC Takes Position in Novo Nordisk A/S $NVOOctober 17 at 4:23 AM | marketbeat.comNovo Nordisk shares fall 5% after Trump vows weight-loss drug price cutOctober 17 at 3:21 AM | reuters.comNovo Nordisk A/S (NYSE:NVO) Shares Down 1.1% - Here's WhyOctober 16, 2025 | marketbeat.comTrump says price of Ozempic will be loweredOctober 16, 2025 | reuters.com236,999 Shares in Novo Nordisk A/S $NVO Bought by Barlow Wealth Partners Inc.October 16, 2025 | marketbeat.comNovo Nordisk has reportedly begun U.S. layoffsOctober 16, 2025 | msn.comWCM Investment Management LLC Sells 1,501,152 Shares of Novo Nordisk A/S $NVOOctober 16, 2025 | marketbeat.comAlta Capital Management LLC Buys 19,130 Shares of Novo Nordisk A/S $NVOOctober 16, 2025 | marketbeat.comMutual Advisors LLC Raises Stake in Novo Nordisk A/S $NVOOctober 16, 2025 | marketbeat.comBoston Trust Walden Corp Acquires 6,670 Shares of Novo Nordisk A/S $NVOOctober 16, 2025 | marketbeat.comNovo Nordisk A/S $NVO Shares Sold by Envestnet Portfolio Solutions Inc.October 16, 2025 | marketbeat.comNovo Nordisk Makes $2.1 Billion Rare-Disease Bet After Losing Ground in Obesity RaceOctober 16, 2025 | finance.yahoo.comNovo Nordisk Just Signed a Key Drug Deal With Omeros. Is There Any Room Left for OMER Stock to Run?October 16, 2025 | finance.yahoo.comNovo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s LeadNovo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments...October 15, 2025 | marketbeat.comNovo Nordisk begins round of layoffs in United States, sources sayOctober 15, 2025 | reuters.comNovo Nordisk to Pay Omeros Up to $2.1 Billion For Blood Disease DrugOctober 15, 2025 | wsj.comNovo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease pushOctober 15, 2025 | reuters.comBMO Capital Maintains Novo Nordisk A (NVO) Market Perform RecommendationOctober 15, 2025 | msn.comCwm LLC Increases Stock Holdings in Novo Nordisk A/S $NVOOctober 15, 2025 | marketbeat.comMeet the 1.4% Yield Dividend Stock That Could Soar in 2026October 15, 2025 | fool.comNovo Nordisk A/S $NVO Shares Sold by Aberdeen Group plcOctober 15, 2025 | marketbeat.comFocus: Inside Novo Nordisk's 'Club 5,000' as Danish staff cuts gain paceOctober 15, 2025 | reuters.comNovo Nordisk A/S (NYSE:NVO) Shares Down 1.4% - Time to Sell?October 14, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Given Hold (C) Rating at Weiss RatingsOctober 14, 2025 | marketbeat.comAnalysts Think These Stocks Could More Than Double in Value (NVO)Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.October 14, 2025 | marketbeat.comEquitable Trust Co. Sells 18,042 Shares of Novo Nordisk A/S $NVOOctober 14, 2025 | marketbeat.comNovo Nordisk A/S $NVO Shares Acquired by Naviter Wealth LLCOctober 14, 2025 | marketbeat.comElefante Mark B Has $1.14 Million Stock Holdings in Novo Nordisk A/S $NVOOctober 14, 2025 | marketbeat.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.690.49▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼5546▲NVO Articles Average Week Get the Latest News and Ratings for NVO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Novartis News Today AstraZeneca News Today Sanofi News Today GSK News Today argenex News Today Takeda Pharmaceutical News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
